Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | PKM | P14618 | 1/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | CES2 | O00748 | 1/20 | 0.33 |
| ▸ | CES1 | P23141 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.33 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | KLK7 | P49862 | 1/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
| ▸ | CA1 | P00915 | 1/20 | 0.32 |
| ▸ | CA2 | P00918 | 1/20 | 0.32 |
| ▸ | DAO | P14920 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3063658 | 0.87 | KMT2A (0.38) | MAPTPKMHSD17B10ALDH1A1MEN1 | |
| SCHEMBL31462930 | 0.86 | ALDH1A1 (0.42) | HSD17B10ALDH1A1TDP1MEN1KMT2A | |
| SCHEMBL11274940 | 0.84 | — | — | |
| SCHEMBL301866 | 0.82 | — | — | |
| SCHEMBL972027 | 0.82 | — | — | |
| SCHEMBL353183 | 0.82 | — | — | |
| SCHEMBL13180448 | 0.78 | — | — | |
| SCHEMBL2915232 | 0.78 | CHRNA4 (0.47) | ALDH1A1CES1 | |
| SCHEMBL3384529 | 0.78 | ALDH1A1 (0.45) | MAPTALDH1A1TDP1HPGDHTT | |
| SCHEMBL3058890 | 0.78 | TDP1 (0.45) | MAPTHSD17B10ALDH1A1TDP1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 441 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250332075-A1 | POLYAMIDE MICROCAPSULES | FIRMENICH & CIE (CH) | 2025-10-30 | — | — | US | claimed |
| US-20250312763-A1 | POLYAMIDE MICROCAPSULES | FIRMENICH SA (CH) | 2025-10-09 | — | — | US | claimed |
| CN-120149740-A | Flame-retardant bio-based lithium battery diaphragm and production process thereof | 合肥卓宸新材料科技有限公司 | 2025-06-13 | — | — | CN | claimed |
| CN-120118306-A | Modified furyl polyamide and preparation method thereof | 安徽利科新材料科技有限公司 | 2025-06-10 | — | — | CN | claimed |
| CN-116082634-B | Sulfonic acid group modified furyl polyamide and preparation method and device thereof | 安徽利科新材料科技有限公司 | 2025-05-23 | — | — | CN | claimed |
| WO-2025101819-A1 | ENTRAPPED SMALL AMINES IN NANOPOROUS MATERIALS FOR GAS CAPTURE | THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK (US) | 2025-05-15 | — | — | WO | claimed |
| CN-119971800-A | High-stability anti-pollution efficient composite reverse osmosis membrane and preparation method thereof | 中国矿业大学(北京) | 2025-05-13 | — | — | CN | claimed |
| CN-119944228-A | Bio-based aromatic polyamide lithium battery diaphragm and preparation method thereof | 合肥卓宸新材料科技有限公司 | 2025-05-06 | — | — | CN | claimed |
| CN-119841793-A | 2, 5-Bis (4-fluorobenzoyl) furan and preparation method thereof | 合肥利夫生物科技有限公司 | 2025-04-18 | — | — | CN | claimed |
| WO-2025066071-A1 | SEMI-BIO-BASED POLYAMIDE CONTAINING CROSS-LINKED STRUCTURE, PREPARATION METHOD THEREFOR AND USE THEREOF | 安徽利科新材料科技有限公司 | 2025-04-03 | — | — | WO | claimed |
| WO-2015014465-A1 | NOVEL STERICALLY HINDERED CYCLIC AMINES | CLARIANT INTERNATIONAL LTD (CH) | 2015-02-05 | — | — | WO | claimed |
| EP-2470517-B1 | 2,5-FURAN DICARBOXYLATES COMPRISING ISODECANOLS, AND USE THEREOF | EVONIK DEGUSSA GMBH (DE) | 2014-04-16 | — | — | EP | claimed |
| EP-2470518-B1 | 2,5-FURAN DICARBOXYLATE DERIVATIVES, AND USE THEREOF AS PLASTICIZERS | EVONIK DEGUSSA GMBH (DE) | 2014-04-16 | — | — | EP | claimed |
| US-20120220507-A1 | 2,5-FURAN DICARBOXYLATE DERIVATIVES, AND USE THEREOF AS PLASTICIZERS | EVONIK OXENO GMBH (DE) | 2012-08-30 | — | — | US | claimed |
| US-20120202725-A1 | 2,5-FURAN DICARBOXYLATES COMPRISING ISODECANOLS, AND USE THEREOF | EVONIK OXENO GMBH (DE) | 2012-08-09 | — | — | US | claimed |
| US-20100280186-A1 | FURANIC-MODIFIED AMINE-BASED CURATIVES | BATTELLE MEMORIAL INSTITUTE | 2010-11-04 | — | — | US | claimed |
| US-20090018264-A1 | RESIN COMPOSITION | CANON KABUSHIKI KAISHA (JP) | 2009-01-15 | — | — | US | claimed |
| US-20080207847-A1 | Furanic-modified amine-based curatives | BATTELLE MEMORIAL INSTITUTE | 2008-08-28 | — | — | US | claimed |
| EP-0539870-B1 | Hydrophilic asymmetric chemically resistant polyaramide membranes | HOECHST AG (DE) | 1996-08-28 | — | — | EP | claimed |
| US-5536408-A | ULTRAFILTRATION, BIOCHEMISTRY SUPPORTS | HOECHST AKTIENGESELLSCHAFT (DE) | 1996-07-16 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120220507-A1 | 2,5-FURAN DICARBOXYLATE DERIVATIVES, AND USE THEREOF AS PLASTICIZERS | OGDH, SDHA, SLC16A7 | MAPT 2829/4885PKM 862/4885HSD17B10 88/4885 |
| US-20100280186-A1 | FURANIC-MODIFIED AMINE-BASED CURATIVES | UMPS, SRM, PAM | MAPT 2353/4885PKM 545/4885HSD17B10 2754/4885 |
| US-20250332075-A1 | POLYAMIDE MICROCAPSULES | PSAP, POLI, PGA5 | MAPT 1026/4885PKM 2319/4885HSD17B10 3438/4885 |
| US-20250312763-A1 | POLYAMIDE MICROCAPSULES | PSAP, PPHLN1, PARG | MAPT 1421/4885PKM 1520/4885HSD17B10 3609/4885 |
| US-20080207847-A1 | Furanic-modified amine-based curatives | DDC, AOC1, ESD | MAPT 2609/4885PKM 2487/4885HSD17B10 1560/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.